Reset filter

PEP-Galzelka-Incidence-of-clinically-significant-percutaneous

Use of off label or drugs beyond licence in pain medicine

This document explores the clinical and legal implications of off-label and unlicensed drug use in medicine, specifically focusing on the role of pain medicine practitioners. It discusses the challenges and responsibilities associated with prescribing medications outside of th...

Reg 37 - Training in anaesthesia leading to FANZCA, and accreditation of facilities to deliver this

Regulation 37 - Training in anaesthesia leading to FANZCA, and accreditation of facilities to deliver this curriculum.

ANZCA feedback on AHPRA cosmetic surgery consultation

21 April 2022 letter to Andrew Brown Independent Reviewer of the regulation of health practitioners in cosmetic surgery c/o Ahpra

User guide for PEP supervisors and co-supervisors

A user guide to the ePortfolio platform for Procedures Endorsement Program supervisors

ANZCA Pholcodine Statement September 2023

This statement has been prepared in response to the decision of the Australian Government Therapeutic Goods Administration (TGA) to withdraw pholcodine-containing products from the market. Evidence shows that pholcodine consumption in the 12-month period prior to a general an...

FPM SOT nomination form

Faculty of Pain Medicine supervisor of training nomination form.

Unconfirmed_2023-May-AGM-minutes_final

AGM 2023 May AGM minutes

Peer review of practice (procedures in pain medicine) - guideline

Peer review of practice (procedures in pain medicine) - guideline

ANZCA Concession application form

First  < Prev   ... 91 92 93    Next >  Last Pages: 92 of 93